OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study
Bochao Lin, Anne Alkema, Triinu Peters, et al.
International Journal of Epidemiology (2019) Vol. 48, Iss. 5, pp. 1505-1514
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study
Benjamin I. Perry, Rachel Upthegrove, Nils Kappelmann, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 176-185
Open Access | Times Cited: 134

Genetic analysis of over half a million people characterises C-reactive protein loci
Saredo Said, Raha Pazoki, Ville Karhunen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 127

Association of Antihypertensive Drug Target Genes With Psychiatric Disorders
Solal Chauquet, Zhihong Zhu, Michael O’Donovan, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 6, pp. 623-623
Open Access | Times Cited: 110

Pleiotropy and Cross-Disorder Genetics Among Psychiatric Disorders
Phil H. Lee, Yen‐Chen Anne Feng, Jordan W. Smoller
Biological Psychiatry (2020) Vol. 89, Iss. 1, pp. 20-31
Open Access | Times Cited: 124

Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Laura Orsolini, Fabiola Sarchione, Federica Vellante, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 5, pp. 583-606
Open Access | Times Cited: 88

Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Jih-Kai Huang, Hsiang‐Chun Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4300-4300
Open Access | Times Cited: 55

Genetic evidence for causal effects of immune dysfunction in psychiatric disorders: where are we?
Olena Iakunchykova, Esten H. Leonardsen, Yunpeng Wang
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10

Nongenetic Factors Associated With Psychotic Experiences Among UK Biobank Participants
Bochao Lin, Lotta-Katrin Pries, Halil Suat Sarac, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 9, pp. 857-857
Open Access | Times Cited: 32

Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: A nested case-control study
David Mongan, Subash Raj Susai, Melanie Föcking, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 90-100
Open Access | Times Cited: 17

Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies
Georgios Markozannes, Charalampia Koutsioumpa, Sofia Cividini, et al.
European Journal of Epidemiology (2020) Vol. 36, Iss. 1, pp. 11-36
Open Access | Times Cited: 42

Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies
Emanuele F. Osimo, Luke Baxter, Jan Štochl, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 31

Using Mendelian randomization as the cornerstone for causal inference in epidemiology
Jianguo Xu, Muyang Li, Ya Gao, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 4, pp. 5827-5839
Closed Access | Times Cited: 30

Gut microbiota and blood metabolites: unveiling their roles in hippocampal volume changes through Mendelian randomization and mediation analysis
Zhi Huang, Xia Du, Fangzhou Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access

Socioenvironmental Adversity and Adolescent Psychotic Experiences: Exploring Potential Mechanisms in a UK Longitudinal Cohort
Joanne B. Newbury, Louise Arseneault, Terrie E. Moffitt, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 4, pp. 1042-1054
Open Access | Times Cited: 9

Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets
Rei Aoki, Takeo Saito, Kohei Ninomiya, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 76, Iss. 8, pp. 361-366
Open Access | Times Cited: 15

Schizophrenia and cardiometabolic abnormalities: A Mendelian randomization study
Noushin Saadullah Khani, Marius Cotic, Baihan Wang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 5

Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknowns
Golam M. Khandaker
International Journal of Epidemiology (2019) Vol. 48, Iss. 5, pp. 1516-1518
Open Access | Times Cited: 13

Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania
Peter Memiah, Lilian Nkinda, Mtebe Majigo, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 10

Genetically predicted circulating levels of cytokines and the risk of depression: a bidirectional Mendelian-randomization study
Meiti Wang, Guixiang Jin, Ying Cheng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top